Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment

EBioMedicine(2025)10.1016/j.ebiom.2025.106063Source: DataRank Database

Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment is a research paper published in EBioMedicine (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 2.80)OA: goldTopics (26)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (76)

Jeffrey Annis ORCID,Meike Fünderich ORCID,Jochen Wilhelm,David G. Kiely ORCID,Luke Howard ORCID

Live enrichment

PubMed:41406504 PMC:PMC12768861 OpenAlex:https://openalex.org/W4417497566

NHLBI NIH HHS

Grant: K23 HL153778

NHLBI NIH HHS

Grant: K23 HL151892

Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University

Universities of Giessen and Marburg Lung Center

Deutsches Zentrum für Lungenforschung

Cardiovascular Medical Research and Education Fund

University of Melbourne

Universität zu Köln

Universitätsklinikum Köln

Monash University

National Institutes of Health

FWCI

2.80

Citation Percentile

0.9%

Citation Trend

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.ebiom.2025.106063

publisherhttps://doi.org/10.1016/j.ebiom.2025.106063

publisherhttps://api.elsevier.com/content/article/PII:S2352396425005079?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352396425005079?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41406504

Fields of Study

Pulmonary Hypertension Research and TreatmentsHeart Failure Treatment and ManagementHeart rate and cardiovascular health

MeSH Terms

AdultAge FactorsAgedFemaleHumansHypertension, PulmonaryMaleMiddle AgedRegistriesRisk FactorsSeverity of Illness IndexSex FactorsComorbidityProportional Hazards ModelsKaplan-Meier Estimate

Keywords

DisadvantageDiseaseMEDLINEPulmonary diseaseComorbidityPulmonary hypertensionSex differencesMeta-registry

Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment

FAIR Checklist

Authors (76)

Funding (11 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)